Relationship between plasma concentration and effect of midazolam after oral and intravenous administration.
about
Mechanistic Modeling to Predict Midazolam Metabolite Exposure from In Vitro Data.Propofol versus midazolam regarding their antioxidant activities.Differential depression of neuronal network activity by midazolam and its main metabolite 1-hydroxymidazolam in cultured neocortical slices.The determination of total and unbound midazolam in human plasma. A comparison of high performance liquid chromatography, gas chromatography and gas chromatography/mass spectrometry.Effect of saquinavir-ritonavir on cytochrome P450 3A4 activity in healthy volunteers using midazolam as a probe.Dose equivalence of midazolam and triazolam. A psychometric study based on flicker sensitivity, reaction time and digit symbol substitution test.Midazolam: the first water-soluble benzodiazepine. Pharmacology, pharmacokinetics and efficacy in insomnia and anesthesia.Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteersPharmacology of drugs frequently used in ICUs: midazolam and flumazenil.The use of kinetic-dynamic interactions in the evaluation of drugs.Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.Anaesthetic premedication: aims, assessment and methods.Therapeutic progress--review XXXI. Therapeutic progress in intensive care sedation and analgesia. Part II--Drug selection.Anaesthesia for coronary artery surgery--a plea for a goal-directed approach.MIDAZOLAM, A NEW MORE POTENT BENZODIAZEPINE, COMPARED WITH DIAZEPAM AS SEDATIVE DURING SPINAL ANALGESIA, A RANDOMISED DOUBLE BLIND STUDY.Recovery following sedation with midazolam or diazepam alone or in combination with fentanyl for outpatient surgery.Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration.GABA-ergic control of visual perception in healthy volunteers: effects of midazolam, a benzodiazepine, on spatio-temporal contrast sensitivity.Respiratory and cardiovascular effects in relation to plasma levels of midazolam and diazepam.Rate of change of blood concentrations is a major determinant of the pharmacodynamics of midazolam in rats.Effects of oral and intravenous midazolam, triazolam and flunitrazepam on the sleep-wakefulness cycle of rabbits.Hypnotic efficacy and clinical safety of midazolam in shift-workers.Investigation of an alternative generic model for predicting pharmacokinetic changes during physiological stress.EEG profile of intravenous zolpidem in healthy volunteers.Influence of food on midazolam absorption.Sedative and respiratory effects of intramuscular midazolam as a premedicant: Influence of gender.Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction.Oral midazolam premedication and postoperative behaviour in children.Pharmacokinetics and pharmacodynamics of midazolam after intranasal administration.Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: relating DRL performance to pharmacokinetics.Comparative absorption kinetics of intramuscular midazolam and diazepam.Interaction between grapefruit juice and midazolam in humans.Pharmacokinetics of midazolam administered concurrently with ketamine after intravenous bolus or infusion in dogs.Reversal of prolonged sedation using flumazenil in critically ill patients.Reversal of sedation by prolonged infusion of flumazenil (Anexate, Ro 15-1788).The effect of midazolam (Hypnovel) administration on antipyrine pharmacokinetics in humans.The effect of midazolam administration on the pharmacokinetics of antipyrine in the rat.Failure of critically ill patients to metabolise midazolam.
P2860
Q31054926-1E1B0787-3A04-4C16-9EA2-C5C25BD82005Q32032727-DAF6DF15-C32B-4D0F-923B-1F42475999E5Q33799458-2BAEE924-EED3-43D2-97AB-493AF1DE4648Q34459897-8CD67BAC-31AC-4F1D-88D5-85E9E800BB0EQ34612352-C1AA2BB1-E447-447A-8E34-41A6B8F9384DQ34677362-7FE6BE3A-B01D-4F1B-A1C0-5A17999595FBQ34686236-E04AA757-02AF-4C44-949C-0B7FEB584A90Q35803814-BA5CA152-913A-4B4E-84A4-04F5796AF6A8Q36923576-3E8E13E7-D07D-444D-A58C-369CBA7CE7FCQ37911447-1A43B4B5-2BF1-4E14-A600-987FA0B7FFC3Q38204833-9C276F18-802C-4558-90D4-EB1509D58FE2Q39462713-4554CB91-2844-4866-A46B-10A9E8881110Q39637643-631B6270-536E-468E-8D53-C5F85E5A1782Q40801223-3489C332-BB5C-4CC3-A193-EF1D7406DF68Q41156686-90392D79-D71C-4112-883A-D9567AF0EB82Q41774121-15751217-65A1-4371-AB3A-E30AD7D2672BQ41775186-8A9AE293-44EB-4045-B869-857DA06A1EC2Q41911019-E3380D62-79E2-4CB6-8CB3-AC9840FD37E5Q42097865-2BE68DE7-B04D-4730-967B-91D9849EA06CQ43191710-A4215FAE-A595-4A5A-BA05-2528B4B5B59EQ43262040-DC72C46B-A8C6-4616-9844-1028785D2CFFQ43262049-FBD5D0EF-9330-4239-9D73-9D32053D0DA0Q47990931-08D742CF-E43F-4E78-95F1-AB2E2605F83CQ48852678-CA09F58A-8C85-401E-947D-7F2F19837459Q49027662-8BBF91C8-1539-4880-8EED-F0291F4CEA75Q50046330-367BF8C6-E85C-4CD5-B14C-30DE4C0839C1Q51515564-E83E7C2E-0424-44A7-B053-716E00388826Q51525698-D1316C00-CE01-4901-87DC-5B88E7AC0B0BQ51537340-569D794D-E0EF-40EF-B04E-6FB3834B4E9EQ51564998-3C34D3F6-64AA-4C04-B269-BA5F63AF3382Q51571964-DA7D320D-F074-4F13-9F7A-0F002E458312Q51599931-E56DDD2F-1E02-42FF-B71F-B3736BBE49E5Q51649629-D59FF466-449F-45D9-A30A-B7A7723C50AAQ51752091-E97A5E77-45A9-4771-8449-94C613F15332Q51772835-3616731B-E62C-441D-962D-74C81C500D16Q51788069-78CDD7DB-2578-468C-BCEE-CDBAFA381010Q51788073-0823929C-7607-498A-86EE-E21517F43968Q51789578-5FC73635-D171-419E-82EE-5A012ECA7564
P2860
Relationship between plasma concentration and effect of midazolam after oral and intravenous administration.
description
1983 nî lūn-bûn
@nan
1983 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Relationship between plasma co ...... nd intravenous administration.
@ast
Relationship between plasma co ...... nd intravenous administration.
@en
type
label
Relationship between plasma co ...... nd intravenous administration.
@ast
Relationship between plasma co ...... nd intravenous administration.
@en
prefLabel
Relationship between plasma co ...... nd intravenous administration.
@ast
Relationship between plasma co ...... nd intravenous administration.
@en
P2093
P2860
P1476
Relationship between plasma co ...... nd intravenous administration.
@en
P2093
Crevoisier C
Heizmann P
Ziegler WH
P2860
P304
P356
10.1111/J.1365-2125.1983.TB02271.X
P407
P478
16 Suppl 1
P577
1983-01-01T00:00:00Z